These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38554345)

  • 1. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer.
    Shukla P; Mishra K; Shukla R; Vishwakarma R; Kumari N; Krishnani N; Behari A; Kapoor VK
    J Cancer Res Ther; 2024 Jan; 20(1):349-357. PubMed ID: 38554345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of VEGF-A, HER2/neu, and
    Singh P; Jain SL; Sakhuja P; Agarwal A
    Indian J Pathol Microbiol; 2021; 64(4):687-692. PubMed ID: 34673587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.
    Zhang LQ; Xu XS; Wan Y; Song SD; Wang RT; Chen W; Wang ZX; Chang HL; Wei JC; Dong YF; Liu C
    World J Gastroenterol; 2015 Jan; 21(4):1243-50. PubMed ID: 25632198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ER, PR, and HER-2 Neu and correlation with tumor markers in gall bladder carcinoma.
    Mani R; Gupta A; Gupta S; Goyal B; Mishra R; Tandon A; Sharma O; Rohilla KK; Kishore S; Dhar P
    J Cancer Res Ther; 2023; 19(5):1279-1287. PubMed ID: 37787296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
    Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
    World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
    Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
    Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival.
    Ochs AM; Wong L; Kakani V; Neerukonda S; Gorske J; Rao A; Riggs M; Ward H; Keville L
    Clin Colorectal Cancer; 2004 Nov; 4(4):262-7. PubMed ID: 15555209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic target.
    Jain P; Goyal S; Chauhan G; Majumdar K; Ali S; Sakhuja P; Agarwal AK
    Indian J Pathol Microbiol; 2020; 63(2):214-220. PubMed ID: 32317518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.
    Li Q; Wang D; Li J; Chen P
    BMC Cancer; 2011 Jun; 11():277. PubMed ID: 21708009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
    Zhou N; Cheng W; Peng C; Liu Y; Jiang B
    Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
    Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
    Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer.
    Wang RT; Miao RC; Zhang X; Yang GH; Mu YP; Zhang ZY; Qu K; Liu C
    World J Gastroenterol; 2021 Feb; 27(8):692-707. PubMed ID: 33716448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer.
    Kwon CH; Seo HI; Kim DU; Han SY; Kim S; Lee SJ; Jeon DY
    Eur J Surg Oncol; 2023 Feb; 49(2):392-398. PubMed ID: 36369228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
    BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.
    Letelier P; Garcia P; Leal P; Ili C; Buchegger K; Riquelme I; Sandoval A; Tapia O; Roa JC
    Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):530-6. PubMed ID: 24185122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
    Saad RS; Liu Y; Han H; Landreneau RJ; Silverman JF
    Mod Pathol; 2004 Oct; 17(10):1235-42. PubMed ID: 15167937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.
    Konecny GE; Meng YG; Untch M; Wang HJ; Bauerfeind I; Epstein M; Stieber P; Vernes JM; Gutierrez J; Hong K; Beryt M; Hepp H; Slamon DJ; Pegram MD
    Clin Cancer Res; 2004 Mar; 10(5):1706-16. PubMed ID: 15014023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study.
    Samuel S; Mukherjee S; Ammannagari N; Pokuri VK; Kuvshinoff B; Groman A; LeVea CM; Iyer R
    PLoS One; 2018; 13(6):e0198809. PubMed ID: 29889907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.